Brief: Genfit Says Phase 2 Interim Data Readout From Lead Program Versus-01 In Aclf Targeted For Q2, 2024
16/11/2023 21:12
Nov 16 (Reuters) - Genfit Sa GNFT.PA :
* GENFIT HIGHLIGHTS ACLF DEVELOPMENT STRATEGY AT “ACLF DAY”
DURING
AASLD THE LIVER MEETING® 2023
* PHASE 2 INTERIM DATA READOUT FROM LEAD PROGRAM VERSUS-01
IN ACLF
TARGETED FOR 2Q24
Source text for Eikon: ID:nGNEbQkLyp
Further company coverage: GNFT.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genfit SA
See all newsFrance's Genfit H1 revenue falls due to absence of milestone payments
French and Benelux stocks-Factors to watch on September 15
Brief: Genfit SA - Advances Nangibotide In Phase 2 Clinical Investigation In Aclf
Brief: Euronext Includes Genfit, Inventiva In SBF120 Index; Interparfums, Verallia Excluded
Brief: Genfit March 31 Cash And Cash Equivalents EUR 136.1 Million